Insulin aspart, recombinant Subcutaneous and Mirvaso topical
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Mirvaso topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: brimonidine topical
Brand name: Mirvaso, Mirvaso Pump
Synonyms: Mirvaso Gel, Mirvaso
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Misoprostol
- Insulin aspart, recombinant Subcutaneous-Mitigare
- Insulin aspart, recombinant Subcutaneous-Mitigo injection
- Insulin aspart, recombinant Subcutaneous-Mitomycin
- Insulin aspart, recombinant Subcutaneous-MitoMYcin (Systemic)
- Insulin aspart, recombinant Subcutaneous-Mitomycin Intravenous
- Mirvaso topical-Insulin degludec
- Mirvaso topical-Insulin Degludec (U-100) Prefilled Pens
- Mirvaso topical-Insulin Degludec (U-100) Vials
- Mirvaso topical-Insulin Degludec (U-200) Prefilled Pens
- Mirvaso topical-Insulin degludec and liraglutide
- Mirvaso topical-Insulin degludec and liraglutide Subcutaneous